User profiles for Peter J. Walter
Peter WalterUniversity of California, San Francisco Verified email at walterlab.ucsf.edu Cited by 104487 |
[PDF][PDF] Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake
…, I Rozga, M Stagliano, M Walter, PJ Walter… - Cell metabolism, 2019 - cell.com
We investigated whether ultra-processed foods affect energy intake in 20 weight-stable adults,
aged (mean ± SE) 31.2 ± 1.6 years and BMI = 27 ± 1.5 kg/m 2 . Subjects were admitted to …
aged (mean ± SE) 31.2 ± 1.6 years and BMI = 27 ± 1.5 kg/m 2 . Subjects were admitted to …
Persistent metabolic adaptation 6 years after “The Biggest Loser” competition
Objective To measure long‐term changes in resting metabolic rate (RMR) and body
composition in participants of “The Biggest Loser” competition. Methods Body composition was …
composition in participants of “The Biggest Loser” competition. Methods Body composition was …
[PDF][PDF] Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity
Dietary carbohydrate restriction has been purported to cause endocrine adaptations that
promote body fat loss more than dietary fat restriction. We selectively restricted dietary …
promote body fat loss more than dietary fat restriction. We selectively restricted dietary …
[HTML][HTML] Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity
…, CM Millo, W Dieckmann, M Walter… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Mirabegron is a β3-adrenergic receptor (β3-AR) agonist approved only for
the treatment of overactive bladder. Encouraging preclinical results suggest that β3-AR …
the treatment of overactive bladder. Encouraging preclinical results suggest that β3-AR …
Development and validation of the new EPA microwave-assisted leach method 3051A
DD Link, PJ Walter, HM Kingston - Environmental Science & …, 1998 - ACS Publications
An updated, optimized method has been developed to minimize the chemical biases and
inefficiencies between two EPA SW-846 alternative leach methods, microwave-assisted …
inefficiencies between two EPA SW-846 alternative leach methods, microwave-assisted …
Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a β3-adrenergic receptor agonist
…, EY Chen, F Gao, NR Narain, MA Kiebish, PJ Walter… - Diabetes, 2018 - Am Diabetes Assoc
β3-adrenergic receptor (AR) agonists are approved to treat only overactive bladder. However,
rodent studies suggest that these drugs could have other beneficial effects on human …
rodent studies suggest that these drugs could have other beneficial effects on human …
[HTML][HTML] Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis
Oxidative stress (OS) in non-alcoholic fatty liver disease (NAFLD) promotes liver injury and
inflammation. Treatment with vitamin E (α-tocopherol, αT), a lipid-soluble antioxidant, …
inflammation. Treatment with vitamin E (α-tocopherol, αT), a lipid-soluble antioxidant, …
Nonnutritive sweeteners in breast milk
…, JE Blau, HM Garraffo, PJ Walter… - Journal of Toxicology …, 2015 - Taylor & Francis
Nonnutritive sweeteners (NNS), including saccharin, sucralose, aspartame, and acesulfame-potassium,
are commonly consumed in the general population, and all except for saccharin …
are commonly consumed in the general population, and all except for saccharin …
[HTML][HTML] Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy
…, M Startzell, E Cochran, PJ Walter… - The Journal of …, 2018 - Am Soc Clin Investig
BACKGROUND. Recombinant leptin (metreleptin) ameliorates hyperphagia and metabolic
abnormalities in leptin-deficient humans with lipodystrophy. We aimed to determine whether …
abnormalities in leptin-deficient humans with lipodystrophy. We aimed to determine whether …
[HTML][HTML] Free fatty acid processing diverges in human pathologic insulin resistance conditions
…, M Startzell, M Walter, PJ Walter… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Postreceptor insulin resistance (IR) is associated with hyperglycemia and
hepatic steatosis. However, receptor-level IR (eg, insulin receptor pathogenic variants, INSR) …
hepatic steatosis. However, receptor-level IR (eg, insulin receptor pathogenic variants, INSR) …